GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » Current Deferred Revenue

Arix Bioscience (LSE:ARIX) Current Deferred Revenue : £0.00 Mil (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Arix Bioscience's current deferred revenue for the quarter that ended in Jun. 2023 was £0.00 Mil.

Arix Bioscience Current Deferred Revenue Historical Data

The historical data trend for Arix Bioscience's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience Current Deferred Revenue Chart

Arix Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Arix Bioscience Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arix Bioscience Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Arix Bioscience (LSE:ARIX) Business Description

Traded in Other Exchanges
N/A
Address
50 Duke Street, Duke Street House, London, GBR, W1K 6JL
Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines